Drug approval process in US, Europe and India and its regulatory requirements: A Review

Journal Title: International Journal of Drug Regulatory Affairs - Year 2018, Vol 6, Issue 3

Abstract

Current constrain of Regulatory Affairs reveals diverse countries need to follow different regulatory requirements for marketing authorization Application (MAA) approval of new drugs. In this present exertion, study expresses the drug approval process and regulatory requirements according to US Food and Drug Administration (UDFDA), European Medical Agency (EMA) and Central Drug Standard Control Organization (CDSCO) (1).

Authors and Affiliations

Krishnasis Chakraborty, Kavita Yadav

Keywords

Related Articles

GLOBAL REGULATORY APPROACH TOWARDS M-HEALTH

The past decade has witnessed rapid advancement in telecommunication and computer technologies. The smart phone is one result of that technological development and has been adopted by hundreds of millions of people world...

GENERIC MEDICINES REGULATION IN BRAZIL

The regulation of medicines in Brazil has proven to be one of the major concerns of government policies in recent decades. In order to improve access to quality medicines for the population, the National Drug Policy was...

Comparative Study of Triglyceride Level in Ischemic Heart Disease Patients in different age groups of Patients in south east Rajasthan

Backgrounds: Elevated body triglycerides have been implicated as a risk factor of ischemic heart disease (IHD). Objectives: To study the association of serum triglyceride with ischemic heart disease and to assess the rel...

THE PATH OF PERSONALIZED MEDICINE: REGULATORY PERSPECTIVE

Personalized medicine (PM) has become a topic of great interest because of its potential to improve patient care and optimize therapeutic strategy. The way we understand and treat disease is changing rapidly. The traditi...

NUTRACEUTICALS - A REGULATORY REVIEW

The Nutraceuticals are the emerging sector in the Pharma Industry. As people are more and more concerned about their health and diseases caused by the malnutrition, the growth of the Nutraceuticals worldwide are inevitab...

Download PDF file
  • EP ID EP426930
  • DOI 10.22270/ijdra.v6i3.266
  • Views 129
  • Downloads 0

How To Cite

Krishnasis Chakraborty, Kavita Yadav (2018). Drug approval process in US, Europe and India and its regulatory requirements: A Review. International Journal of Drug Regulatory Affairs, 6(3), 31-39. https://europub.co.uk/articles/-A-426930